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Biotechnology and Food Safety
Creat economic and social forces flow like a tide over half-conscious people. The 
wise are those who foresee the coming event and seek to shape their institutions and 
mold the thinking of the people in accordance with the most constructive change.
The unwise are those who add nothing constructive to the process, either because of 
ignorance on the one hand or ignorant opposition on the other.
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Biotechnology will yield an expanding array of new 
foods, food ingredients, food additives and new pro­
cesses to produce existing products. These include 
bruise-free fruit, crisper celery and sweeter carrots, caf­
feine-free coffee beans, and low-calorie sweeteners. 
The Food and Drug Administration (FDA) recently ap­
proved rennet, the first biotechnologically produced 
enzyme approved for use in food. Much animal bio­
technology research focuses on producing transgenic 
livestock and poultry that will utilize feed more effi­
ciently, grow to desired slaughter weights at an earlier 
age, and be resistant to a variety of diseases. Farmers 
stand to benefit from reduced production costs, im­
proved efficiencies, and higher quality products. Con­
sumers will benefit because farmers will be able to sup­
ply leaner meat and poultry produced with a decreased 
dependence on vaccines, drugs and insecticides. In ad­
dition, consumers may see reduced prices at the grocery 
store, since farmers will produce animals of the same 
weight as is currently produced, but in a shorter period 
of time with lower production costs.
While these products and events are exciting possi­
bilities, difficult decisions lie ahead in biotechnology. 
For example, bovine somatotropin (BST) which only 
needs to pass long-term animal health tests before re-
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ceiving FDA approval, holds great promise for dairy 
farmers. Bovine somatotropin has been declared safe 
by FDA; yet it continues to be the target of food 
safety accusations.
Food safety is an easy target for biotechnology critics, 
as consumers are already confused and worried about 
food safety. A recent survey by the Food Marketing 
Institute reported that only 15 percent of those sur­
veyed were “completely confident” that the food sold in grocery stores is 
safe. Sixty-four percent of consumers said they were “mostly confident” 
about supermarket food.
A recent Michigan Department of Agriculture survey indicated consu­
mer confidence in food had declined and that food safety depended upon 
government inspection and regulation. Those surveyed said increased food 
product testing was the single best method to improve food safety. From 
the perspective of the FDA this may appear to be a positive finding, how­
ever, it gives rise to a concern that some consumers feel that more sampling 
and testing is the single key to safer food.
Sampling and testing are important for detecting potential violations 
and problems, but detection is not the optimal way to ensure food safety. 
At the Food Safety and Inspection Service ( FSIS), the emphasis is on pre­
venting rather than detecting food borne contamination. Prevention is the 
best way to deal with drug abuse, and it is the best way to ensure food 
safety. To best prevent food safety problems, government, industry and 
consumers must acknowledge their respective responsibilities for ensuring 
safe food. The inspection services are becoming more science driven, and 
intend for their evaluation of biotechnology products to be based on sound 
science.
The Food Safety and Inspection Service is responsible for ensuring the 
safety and wholesomeness of meat and poultry. Last year, 121 million head 
of livestock, almost 5.9 billion birds, and 150 billion pounds of processed 
product were inspected. The Food Safety and Inspection Service is the 
agency that provides the final assurance that the meat and poultry prod­
ucts of biotechnology are safe. Some food safety responsibilities are shared 
with other agencies. In order to ensure that plans for new products are 
well coordinated, a Food Animal Biotechnology Information Exchange 
Group has been organized. Representatives from USDA, which includes 
FSIS and the Animal and Plant Health Inspection Service (APHIS); FDA
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which includes the Center for Veterinary Medicine and the Center for Food 
Safety and Applied Nutrition; and the Environmental Protection Agency 
(EPA) meet regularly to consider jurisdictional issues and anticipate prob­
lems and concerns.
Bringing improved foods to market requires the scientific assurance of 
safety. Biotechnology products are expected to be safe, but that safety 
must be demonstrated and documented to ensure 
public health and to win public confidence. At FSIS, 
animal products of biotechnology will be reviewed 
and approved under existing regulations. A formal po­
sition is currently being developed regarding how 
products of biotechnology that affect the meat and 
poultry industry will be reviewed and evaluated. The 
current position is based on technology as it is now, 
but the position will evolve over time to keep pace as 
new technology becomes available and as scientific findings point to the 
need for changes. We want our regulatory process for biotechnology to be a 
public one. Surprises do not do anyone any good. We cannot afford to oper­
ate behind closed doors with consumers questioning our actions or deci­
sions. We intend to share our recommendations with USDA's Agricultural 
Biotechnology Research Advisory Committee to ensure all scientific con­
siderations have been taken into account. Scientific considerations are our 
number one priority.
Food safety decisions must be based on the best science available. Emo­
tional and socioeconomic issues, while important, cannot play a role in de­
termining the food safety of biotechnology products.
There are two main areas to review in the current thinking on evaluat­
ing the safety of biotechnology products for the meat and poultry indus­
try: substances added to meat and poultry products, and transgenic ani­
mals that carry a desired gene.
Substances added to meat and poultry products With a biotechno- 
logically-derived enzyme, flavoring or other food additive, FDA is the 
agency responsible for approving the products for safety. Once the prod­
ucts have been approved by FDA, a safety and efficacy evaluation will be 
conducted for the specific use of the product in meat and poultry products 
at defined concentrations and specific formulations. This secondary re­
view certifies the substance as safe and effective in meat and poultry in its 
planned use and that it presents no nutritional or other concerns.
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Transgenic Animals The safety assessment of transgenic animals 
should be conceptually very similar to the evaluation of traditional ani­
mals. Biotechnology merely provides methods for making well-understood 
and precise genetic changes. In most cases, the changes themselves will be 
modest, directed at health, disease prevention and nutritional quality. In 
fact, the precise nature of the genetic change is known with transgenic ani­
mals, directing the safety inquiry to the appropriate issues. Traditional 
breeding provides no such clues. Also, if the animal containing the desired 
genetic material is healthy, it is very likely the animal will be safe to eat. 
Just as is the case with traditional animals, the health of the animal is an 
important indicator of its safety.
The safety evaluation of transgenic animals focuses on two topics: the 
genetic insert and the nature of the gene product. The genetic insert is
the piece of DNA added to the genome of transgenic animals. Unless it is 
infectious, it is of no consequence. The DNA of ani­
mals and plants that are consumed is all part of the 
food.
Although the gene product must be examined care­
fully, the safety questions are not new. Genes produce 
proteins, the evaluation of which is not new. Genes 
produce proteins and the evaluation of proteins is a routine food safety 
consideration. The FDA will be consulted on animal drug and other phar­
macological products, and EPA on gene products that have pesticidal activ­
ity. If the protein product is alleged to be identical to other proteins already 
in the diet, we will require data to support its identity. In all cases, we will 
use existing tolerances and safety considerations for gene products that 
have the same effect as traditionally produced drugs, pesticides or addi­
tives.
Should biotechnology provide new products for which there are no tol­
erances or safety guidelines, we will require the appropriate toxicity and 
pharmacokinetic data to ensure the safety of the product.
To summarize our regulatory plans, FS1S expects that once the safety of 
the gene product is established, transgenic animals are likely to require 
similar safety considerations as traditional animals.
The use of biotechnology is not always an appropriate trigger for over­
sight. However, the method of production should not be ignored. As in the 
safety review of traditionally produced food additives, the safety assess­
ment takes into account contaminants likely to result from the particular
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process. The same will be done with products of biotechnology. Plans for 
regulating biotechnology products will afford consumers the same high 
level of safety and confidence they have enjoyed for years. Science will 
drive FSIS decisions. Hopefully science will drive regulatory decisions 
worldwide.
Biotechnology is international in scope and it is imperative that its 
safety be judged with scientific standards. We intend to work with Codex 
and other international organizations such as the International Plant Pro­
tection Conference and the International Office of Epizootics to review in­
ternational food standards as they relate to biotechnology. These groups 
can help coordinate scientific standards that ensure the food safety of bio­
technology products. Harmonized food safety standards will help settle in­
ternational disputes, reduce trade conflicts and improve consumer confi­
dence.
Codex will hold a biotechnology consultation in November, 1990, at 
which experts will discuss the food safety implications of biotechnology 
and will determine whether there are any food safety questions that can­
not be handled by the current Codex organizational structure. The United 
States is also working with the European Community (EC) to resolve food 
safety disputes. Secretary of Agriculture Clayton Yeutter and Under Secre­
tary Richard Crowder met in early June with their counterparts from the 
Office of European Community Development. The Secretary has also set 
up regular consultations with the European Community’s Director Gene­
ralship for Agriculture to discuss food safety. These forums should prove 
useful in discussing potential disputes early rather than waiting for con­
flicts to arise.
Biotechnology will see its share of conflict. It is a new technology that is 
entering the marketplace at a time when consumers are anxious about the 
use of technology in food production. Consumers want “natural” products 
that are free of synthetic additives. They also want nutritious, convenient, 
high quality, well-packaged foods—all of which require technology. Bio­
technology will help give consumers what they want.
Biotechnology will help fight bacteria that contaminate food. Biotech­
nology can reduce the fat in meat products and add nutritional value to 
other products. A long road lies ahead in convincing the American public 
that technology and its use in food production is not bad, and FSIS is com­
mitted to helping consumers understand the role of technology—including 
biotechnology— in food production and safety. Biotechnology critics are
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poised to impugn food safety as a rallying point against the new technol­
ogy. The government, along with the food and biotechnology industry, 
must use sound science to prove food safety and to stand behind our public 
health decisions. If emotions were allowed to overrule sound science, un­
justified food safety scares are risked along with a total loss in consumer 
confidence. We would also be breaking our trust with the public, which ex­
pects us to do the right thing, even when it is difficult and controversial.
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